Abstract
MicroRNAs (miRNAs) play key regulatory roles in diverse biological processes and are frequently dysregulated in human diseases. Thus, miRNAs have emerged as a class of promising targets for therapeutic intervention. Here, we describe the current strategies for therapeutic modulation of miRNAs and provide an update on the development of miRNA‐based therapeutics for the treatment of cancer, cardiovascular disease and hepatitis C virus (HCV) infection.

This publication has 122 references indexed in Scilit: